 | • レポートコード：QYR2104Z4431 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、副甲状腺障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（副甲状腺機能亢進症、副甲状腺がん、副甲状腺機能低下症）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・副甲状腺障害の市場動向 ・企業の競争状況、市場シェア ・副甲状腺障害の種類別市場規模（副甲状腺機能亢進症、副甲状腺がん、副甲状腺機能低下症） ・副甲状腺障害の用途別市場規模（病院、専門クリニック、その他） ・副甲状腺障害の北米市場規模2016-2027（アメリカ、カナダ） ・副甲状腺障害のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・副甲状腺障害のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・副甲状腺障害の中南米市場規模2016-2027（メキシコ、ブラジル） ・副甲状腺障害の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Alcon Laboratories、Amgen、Bayer Healthcare、Becton, Dickinson and Company、Eli Lilly、Ethicon） ・結論 |
Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.
Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hypoparathyroidism most often occurs after neck surgery; it can also be caused by autoimmune destruction of the glands and other less common problems. Evaluation of patients with abnormal serum calcium levels includes a history and physical examination; repeat measurement of serum calcium level; and measurement of creatinine, magnesium, vitamin D, and parathyroid hormone levels. The treatment for symptomatic primary hyperparathyroidism is parathyroidectomy. Management of asymptomatic primary hyperparathyroidism includes monitoring symptoms; serum calcium and creatinine levels; and bone mineral density. Patients with hypoparathyroidism require close monitoring and vitamin D (e.g., calcitriol) replacement.
Market Analysis and Insights: Global Parathyroid Disorders Market
The global Parathyroid Disorders market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parathyroid Disorders market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parathyroid Disorders market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parathyroid Disorders market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parathyroid Disorders market.
Global Parathyroid Disorders Scope and Market Size
Parathyroid Disorders market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parathyroid Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hyperparathyroidism
Parathyroid Cancer
Hypoparathyroidism
Segment by Application
Hospitals
Specialty Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Alcon Laboratories
Amgen
Bayer Healthcare
Becton, Dickinson and Company
Eli Lilly
Ethicon
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parathyroid Disorders Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hyperparathyroidism
1.2.3 Parathyroid Cancer
1.2.4 Hypoparathyroidism
1.3 Market by Application
1.3.1 Global Parathyroid Disorders Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parathyroid Disorders Market Perspective (2016-2027)
2.2 Parathyroid Disorders Growth Trends by Regions
2.2.1 Parathyroid Disorders Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parathyroid Disorders Historic Market Share by Regions (2016-2021)
2.2.3 Parathyroid Disorders Forecasted Market Size by Regions (2022-2027)
2.3 Parathyroid Disorders Industry Dynamic
2.3.1 Parathyroid Disorders Market Trends
2.3.2 Parathyroid Disorders Market Drivers
2.3.3 Parathyroid Disorders Market Challenges
2.3.4 Parathyroid Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parathyroid Disorders Players by Revenue
3.1.1 Global Top Parathyroid Disorders Players by Revenue (2016-2021)
3.1.2 Global Parathyroid Disorders Revenue Market Share by Players (2016-2021)
3.2 Global Parathyroid Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parathyroid Disorders Revenue
3.4 Global Parathyroid Disorders Market Concentration Ratio
3.4.1 Global Parathyroid Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parathyroid Disorders Revenue in 2020
3.5 Parathyroid Disorders Key Players Head office and Area Served
3.6 Key Players Parathyroid Disorders Product Solution and Service
3.7 Date of Enter into Parathyroid Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parathyroid Disorders Breakdown Data by Type
4.1 Global Parathyroid Disorders Historic Market Size by Type (2016-2021)
4.2 Global Parathyroid Disorders Forecasted Market Size by Type (2022-2027)
5 Parathyroid Disorders Breakdown Data by Application
5.1 Global Parathyroid Disorders Historic Market Size by Application (2016-2021)
5.2 Global Parathyroid Disorders Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Parathyroid Disorders Market Size (2016-2027)
6.2 North America Parathyroid Disorders Market Size by Type
6.2.1 North America Parathyroid Disorders Market Size by Type (2016-2021)
6.2.2 North America Parathyroid Disorders Market Size by Type (2022-2027)
6.2.3 North America Parathyroid Disorders Market Size by Type (2016-2027)
6.3 North America Parathyroid Disorders Market Size by Application
6.3.1 North America Parathyroid Disorders Market Size by Application (2016-2021)
6.3.2 North America Parathyroid Disorders Market Size by Application (2022-2027)
6.3.3 North America Parathyroid Disorders Market Size by Application (2016-2027)
6.4 North America Parathyroid Disorders Market Size by Country
6.4.1 North America Parathyroid Disorders Market Size by Country (2016-2021)
6.4.2 North America Parathyroid Disorders Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Parathyroid Disorders Market Size (2016-2027)
7.2 Europe Parathyroid Disorders Market Size by Type
7.2.1 Europe Parathyroid Disorders Market Size by Type (2016-2021)
7.2.2 Europe Parathyroid Disorders Market Size by Type (2022-2027)
7.2.3 Europe Parathyroid Disorders Market Size by Type (2016-2027)
7.3 Europe Parathyroid Disorders Market Size by Application
7.3.1 Europe Parathyroid Disorders Market Size by Application (2016-2021)
7.3.2 Europe Parathyroid Disorders Market Size by Application (2022-2027)
7.3.3 Europe Parathyroid Disorders Market Size by Application (2016-2027)
7.4 Europe Parathyroid Disorders Market Size by Country
7.4.1 Europe Parathyroid Disorders Market Size by Country (2016-2021)
7.4.2 Europe Parathyroid Disorders Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Parathyroid Disorders Market Size (2016-2027)
8.2 Asia-Pacific Parathyroid Disorders Market Size by Type
8.2.1 Asia-Pacific Parathyroid Disorders Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parathyroid Disorders Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parathyroid Disorders Market Size by Type (2016-2027)
8.3 Asia-Pacific Parathyroid Disorders Market Size by Application
8.3.1 Asia-Pacific Parathyroid Disorders Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parathyroid Disorders Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parathyroid Disorders Market Size by Application (2016-2027)
8.4 Asia-Pacific Parathyroid Disorders Market Size by Region
8.4.1 Asia-Pacific Parathyroid Disorders Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parathyroid Disorders Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Parathyroid Disorders Market Size (2016-2027)
9.2 Latin America Parathyroid Disorders Market Size by Type
9.2.1 Latin America Parathyroid Disorders Market Size by Type (2016-2021)
9.2.2 Latin America Parathyroid Disorders Market Size by Type (2022-2027)
9.2.3 Latin America Parathyroid Disorders Market Size by Type (2016-2027)
9.3 Latin America Parathyroid Disorders Market Size by Application
9.3.1 Latin America Parathyroid Disorders Market Size by Application (2016-2021)
9.3.2 Latin America Parathyroid Disorders Market Size by Application (2022-2027)
9.3.3 Latin America Parathyroid Disorders Market Size by Application (2016-2027)
9.4 Latin America Parathyroid Disorders Market Size by Country
9.4.1 Latin America Parathyroid Disorders Market Size by Country (2016-2021)
9.4.2 Latin America Parathyroid Disorders Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parathyroid Disorders Market Size (2016-2027)
10.2 Middle East & Africa Parathyroid Disorders Market Size by Type
10.2.1 Middle East & Africa Parathyroid Disorders Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parathyroid Disorders Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parathyroid Disorders Market Size by Type (2016-2027)
10.3 Middle East & Africa Parathyroid Disorders Market Size by Application
10.3.1 Middle East & Africa Parathyroid Disorders Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parathyroid Disorders Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parathyroid Disorders Market Size by Application (2016-2027)
10.4 Middle East & Africa Parathyroid Disorders Market Size by Country
10.4.1 Middle East & Africa Parathyroid Disorders Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parathyroid Disorders Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Parathyroid Disorders Introduction
11.1.4 Abbott Laboratories Revenue in Parathyroid Disorders Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Alcon Laboratories
11.2.1 Alcon Laboratories Company Details
11.2.2 Alcon Laboratories Business Overview
11.2.3 Alcon Laboratories Parathyroid Disorders Introduction
11.2.4 Alcon Laboratories Revenue in Parathyroid Disorders Business (2016-2021)
11.2.5 Alcon Laboratories Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Parathyroid Disorders Introduction
11.3.4 Amgen Revenue in Parathyroid Disorders Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Bayer Healthcare
11.4.1 Bayer Healthcare Company Details
11.4.2 Bayer Healthcare Business Overview
11.4.3 Bayer Healthcare Parathyroid Disorders Introduction
11.4.4 Bayer Healthcare Revenue in Parathyroid Disorders Business (2016-2021)
11.4.5 Bayer Healthcare Recent Development
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Details
11.5.2 Becton, Dickinson and Company Business Overview
11.5.3 Becton, Dickinson and Company Parathyroid Disorders Introduction
11.5.4 Becton, Dickinson and Company Revenue in Parathyroid Disorders Business (2016-2021)
11.5.5 Becton, Dickinson and Company Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Parathyroid Disorders Introduction
11.6.4 Eli Lilly Revenue in Parathyroid Disorders Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Ethicon
11.7.1 Ethicon Company Details
11.7.2 Ethicon Business Overview
11.7.3 Ethicon Parathyroid Disorders Introduction
11.7.4 Ethicon Revenue in Parathyroid Disorders Business (2016-2021)
11.7.5 Ethicon Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Parathyroid Disorders Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hyperparathyroidism
Table 3. Key Players of Parathyroid Cancer
Table 4. Key Players of Hypoparathyroidism
Table 5. Global Parathyroid Disorders Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Parathyroid Disorders Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Parathyroid Disorders Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Parathyroid Disorders Market Share by Regions (2016-2021)
Table 9. Global Parathyroid Disorders Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Parathyroid Disorders Market Share by Regions (2022-2027)
Table 11. Parathyroid Disorders Market Trends
Table 12. Parathyroid Disorders Market Drivers
Table 13. Parathyroid Disorders Market Challenges
Table 14. Parathyroid Disorders Market Restraints
Table 15. Global Parathyroid Disorders Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Parathyroid Disorders Market Share by Players (2016-2021)
Table 17. Global Top Parathyroid Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parathyroid Disorders as of 2020)
Table 18. Ranking of Global Top Parathyroid Disorders Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Parathyroid Disorders Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Parathyroid Disorders Product Solution and Service
Table 22. Date of Enter into Parathyroid Disorders Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Parathyroid Disorders Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Parathyroid Disorders Revenue Market Share by Type (2016-2021)
Table 26. Global Parathyroid Disorders Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Parathyroid Disorders Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Parathyroid Disorders Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Parathyroid Disorders Revenue Market Share by Application (2016-2021)
Table 30. Global Parathyroid Disorders Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Parathyroid Disorders Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Parathyroid Disorders Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Parathyroid Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Parathyroid Disorders Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Parathyroid Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Parathyroid Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Parathyroid Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Parathyroid Disorders Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Parathyroid Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Parathyroid Disorders Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Parathyroid Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Parathyroid Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Parathyroid Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Parathyroid Disorders Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Parathyroid Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Parathyroid Disorders Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Parathyroid Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Parathyroid Disorders Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Parathyroid Disorders Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Parathyroid Disorders Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Parathyroid Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Parathyroid Disorders Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Parathyroid Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Parathyroid Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Parathyroid Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Parathyroid Disorders Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Parathyroid Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Parathyroid Disorders Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Parathyroid Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Parathyroid Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Parathyroid Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Parathyroid Disorders Product
Table 65. Abbott Laboratories Revenue in Parathyroid Disorders Business (2016-2021) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Alcon Laboratories Company Details
Table 68. Alcon Laboratories Business Overview
Table 69. Alcon Laboratories Parathyroid Disorders Product
Table 70. Alcon Laboratories Revenue in Parathyroid Disorders Business (2016-2021) & (US$ Million)
Table 71. Alcon Laboratories Recent Development
Table 72. Amgen Company Details
Table 73. Amgen Business Overview
Table 74. Amgen Parathyroid Disorders Product
Table 75. Amgen Revenue in Parathyroid Disorders Business (2016-2021) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. Bayer Healthcare Company Details
Table 78. Bayer Healthcare Business Overview
Table 79. Bayer Healthcare Parathyroid Disorders Product
Table 80. Bayer Healthcare Revenue in Parathyroid Disorders Business (2016-2021) & (US$ Million)
Table 81. Bayer Healthcare Recent Development
Table 82. Becton, Dickinson and Company Company Details
Table 83. Becton, Dickinson and Company Business Overview
Table 84. Becton, Dickinson and Company Parathyroid Disorders Product
Table 85. Becton, Dickinson and Company Revenue in Parathyroid Disorders Business (2016-2021) & (US$ Million)
Table 86. Becton, Dickinson and Company Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Parathyroid Disorders Product
Table 90. Eli Lilly Revenue in Parathyroid Disorders Business (2016-2021) & (US$ Million)
Table 91. Eli Lilly Recent Development
Table 92. Ethicon Company Details
Table 93. Ethicon Business Overview
Table 94. Ethicon Parathyroid Disorders Product
Table 95. Ethicon Revenue in Parathyroid Disorders Business (2016-2021) & (US$ Million)
Table 96. Ethicon Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parathyroid Disorders Market Share by Type: 2020 VS 2027
Figure 2. Hyperparathyroidism Features
Figure 3. Parathyroid Cancer Features
Figure 4. Hypoparathyroidism Features
Figure 5. Global Parathyroid Disorders Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Specialty Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Parathyroid Disorders Report Years Considered
Figure 10. Global Parathyroid Disorders Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Parathyroid Disorders Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Parathyroid Disorders Market Share by Regions: 2020 VS 2027
Figure 13. Global Parathyroid Disorders Market Share by Regions (2022-2027)
Figure 14. Global Parathyroid Disorders Market Share by Players in 2020
Figure 15. Global Top Parathyroid Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parathyroid Disorders as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Parathyroid Disorders Revenue in 2020
Figure 17. Global Parathyroid Disorders Revenue Market Share by Type (2016-2021)
Figure 18. Global Parathyroid Disorders Revenue Market Share by Type (2022-2027)
Figure 19. North America Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Parathyroid Disorders Market Share by Type (2016-2027)
Figure 21. North America Parathyroid Disorders Market Share by Application (2016-2027)
Figure 22. North America Parathyroid Disorders Market Share by Country (2016-2027)
Figure 23. United States Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Parathyroid Disorders Market Share by Type (2016-2027)
Figure 27. Europe Parathyroid Disorders Market Share by Application (2016-2027)
Figure 28. Europe Parathyroid Disorders Market Share by Country (2016-2027)
Figure 29. Germany Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Parathyroid Disorders Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Parathyroid Disorders Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Parathyroid Disorders Market Share by Region (2016-2027)
Figure 39. China Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Parathyroid Disorders Market Share by Type (2016-2027)
Figure 47. Latin America Parathyroid Disorders Market Share by Application (2016-2027)
Figure 48. Latin America Parathyroid Disorders Market Share by Country (2016-2027)
Figure 49. Mexico Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Parathyroid Disorders Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Parathyroid Disorders Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Parathyroid Disorders Market Share by Country (2016-2027)
Figure 55. Turkey Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Parathyroid Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Laboratories Revenue Growth Rate in Parathyroid Disorders Business (2016-2021)
Figure 59. Alcon Laboratories Revenue Growth Rate in Parathyroid Disorders Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Parathyroid Disorders Business (2016-2021)
Figure 61. Bayer Healthcare Revenue Growth Rate in Parathyroid Disorders Business (2016-2021)
Figure 62. Becton, Dickinson and Company Revenue Growth Rate in Parathyroid Disorders Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Parathyroid Disorders Business (2016-2021)
Figure 64. Ethicon Revenue Growth Rate in Parathyroid Disorders Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のパニック障害市場規模・現状・予測（2021年-2027年） Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks. Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used inc…- 世界の神経精神障害＆治療市場規模・現状・予測（2021年-2027年） Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions…
- 世界の筋骨格系障害治療市場規模・現状・予測（2021年-2027年） Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body's movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon Market Analysis and Insights: G…
- 世界の膝＆股関節障害市場規模・現状・予測（2021年-2027年） Knee and hip are complex joints in the body. The knee joins the thigh bone (femur) to the shin bone (tibia), whereas the hip joint is a ball-socket synovial joint formed between the os coxa (hip bone) and the femur. To treat knee and hip disorders, implants and surgeries are performed so as to keep …
- 世界のメンデル遺伝病検査市場規模・現状・予測（2021年-2027年） The Mendelian disorder is different types of genetic disorder in humans. These genetic disorders are mainly caused by the changes or alterations in a single gene or due to the abnormalities in the genome. These conditions will be present since the child’s birth and can be predicted based on the hist…